Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by KORU Medical Systems, Inc.

KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems Announces Successful Appeal in EU Notified Body Review
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems Announces 2022 Third Quarter Financial Results
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira Pharmaceuticals
From KORU Medical Systems, Inc.
Via Business Wire
Tickers KRMD
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.